Skip to main content
. 2023 Mar 21;13(3):570. doi: 10.3390/biom13030570

Table 1.

Demographic and clinical characteristics of individuals diagnosed with MCI and AD patients. All data are presented as median (range).

Participants Mann–Whitney U Test
MCI AD U p
Age (years) 71.0
(41.0–88.0)
77.5
(49–94)
32,536.5 <0.001
BMI (kg/m2) 22.0
(18.4–32.4)
23.4
(18.5–31.9)
6935.5 0.354
Waist circumference (cm) 86.0
(71.0–101.0)
86.0
(72.0–99.0)
6459.0 0.986
Total cholesterol (mmol/L) 5.4
(3.2–8.8)
5.7
(3.2–8.8)
6759.0 0.566
HDL-cholesterol (mmol/L) 1.3
(0.7–3.0)
1.3
(0.7–3.0)
6397.0 0.888
LDL-cholesterol (mmol/L) 3.1
(0.8–5.6)
3.3
(0.8–5.8)
7016.0 0.278
Triglycerides 1.8
(0.7–6.7)
1.8
(0.7–6.7)
6756.0 0.569
Blood glucose (mmol/L) 5.5
(4.4–11.8)
5.6
(4.7–11.8)
7191.5 0.153
MMSE score 27.0
(21.0–30.0)
16.5
(0.0–27.0)
1535.5 <0.001
CDT score 5.0
(0.0–5.0)
1.0
(0.0–5.0)
7129.0 <0.001

AD, Alzheimer’s disease; CDT, Clock Drawing test; HDL, high-density lipoproteins; BMI, body mass index; LDL, low-density lipoproteins; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; and N, number of participants.